ReCell Placement and Medical Procedure Overview slide image

ReCell Placement and Medical Procedure Overview

Key Offer Details Offer size and Structure Conditional Placement to raise A$9 million, comprising - 90 million new AVH shares to be issued New shares issued will rank equally in all respects with existing ordinary shares from allotment New shares to be issued subject to shareholder approval - Not underwritten Share Purchase Plan ("SPP") will be provided for eligible shareholders - SPP is capped at A$2 million for a maximum of A$15,000 per eligible shareholder, at the AVH Board's discretion SPP booklet to be mailed to shareholders in due course Not underwritten Pricing - New shares to be issued subject to the Conditional Placement being approved at the EGM Fixed price of A$0.10 per share Discount is based on the AVH closing price as at 13 May 2011 of A$0.150 which represents: 28.6% to the 1-month VWAP (A$0.140) 32.2% to the 5-day VWAP (A$0.148) 33.3% to the last close (A$0.150) Lead Manager Wilson HTM Corporate Finance Ltd 35 medical avita
View entire presentation